首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 (6R,7R)-7-[(Z)-2-(乙氧基亚氨基)-2-(5-(膦酰氨基)-1,2,4-噻二唑-3-基)乙酰胺基]-3-[(4-(1-甲基吡啶-1-鎓-4-基)噻唑-2-基)硫基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸乙酸盐一水合物

(6R,7R)-7-[(Z)-2-(乙氧基亚氨基)-2-(5-(膦酰氨基)-1,2,4-噻二唑-3-基)乙酰胺基]-3-[(4-(1-甲基吡啶-1-鎓-4-基)噻唑-2-基)硫基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸乙酸盐一水合物

(6R,7R)-7-((Z)-2-(ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate--acetic acid (1/1) hydrate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

866021-48-9

中文名称

(6R,7R)-7-[(Z)-2-(乙氧基亚氨基)-2-(5-(膦酰氨基)-1,2,4-噻二唑-3-基)乙酰胺基]-3-[(4-(1-甲基吡啶-1-鎓-4-基)噻唑-2-基)硫基]-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸乙酸盐一水合物

英文名称

(6R,7R)-7-((Z)-2-(ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate--acetic acid (1/1) hydrate

别名

Ceftaroline;Unii-p9vxv1408y;acetic acid,(6R,7R)-7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,hydrate;Ceftaroline Fosamil Acetate Hydrate;Ceftaroline Impurity8;4-[2-[[(6R;4-thiadiazol-3-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]thio]-4-thiazolyl]-1-methylpyridinium acetate hydrate;7R)-2-Carboxy-7-[[(2Z)-(ethoxyimino)[5-(phosphonoamino)-1

标准英文名

(6R,7R)-7-((Z)-2-(ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate--acetic acid (1/1) hydrate

分子式

C24H27N8O11PS4

分子量

762.77

精确分子量

762.04

SMILES

CC(=O)O.CCO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(SC3=NC(C4=CC=[N+](C)C=C4)=CS3)CS[C@H]12)C1=NSC(NP(=O)(O)O)=N1.O

标准SMILES

O.CC(O)=O.CCO/N=C(/C1N=C(NP(O)(O)=O)SN=1)\C(=O)N[C@H]1[C@H]2SCC(SC3=NC(=CS3)C3C=C[N+](C)=CC=3)=C(C([O-])=O)N2C1=O

用途

1) Acute bacterial skin and skin structure infections (ABSSSI): Ceftaroline is indicated for the treatment of ABSSSI caused by susceptible isolates of Gram-positive and Gram-negative microorganisms, including Staphylococcus aureus (both methicillin-resistant and methicillin-susceptible isolates), Streptococcus pyogenes, Streptococcus agalactiae, Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca. 2) Community-acquired bacterial pneumonia (CABP): Ceftaroline is indicated for the treatment of CABP caused by susceptible isolates of Gram-positive and Gram-negative microorganisms, including Streptococcus pneumoniae (including cases with concurrent bacteremia), Staphylococcus aureus (methicillin-susceptible isolates), Haemophilus influenzae, Klebsiella pneumoniae, Klebsiella oxytoca, and Escherichia coli.

InChIKey

KRWPPVCZNGQQHZ-IINIBMQSSA-N

安全信息

SureRoute逆合成路线

1.  866021-48-9 逆合成路线 1

—
—
—
—
ACKVOZ216
866021-48-9
来源: SureRoute

2.  866021-48-9 逆合成路线 2

—
—
—
—
ACKVOZ216
866021-48-9
来源: SureRoute

3.  866021-48-9 逆合成路线 3

—
—
—
—
ACKVOZ216
866021-48-9
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手